Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03238677 · ClinicalTrials.gov registry record · NA
Treating Childhood Apraxia of Speech
A NA study, sponsored by Syracuse University.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT03238677 is a NA study that has completed, run by Syracuse University. The registered enrollment target is 56 participants.
The verdict
NCT03238677, a NA study, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The study will test two modifications to speech therapy for 40 school-age children with childhood apraxia of speech to determine how to improve treatment outcomes. The study will compare treatment that includes real-time visual feedback of the tongue during speech using ultrasound vs traditional therapy that does not include ultrasound visual feedback. Additionally, some children will be treated with a traditional schedule of 2 sessions per week, whereas others will be provided with treatment that begins with intensive training (10 hours of therapy in one week) and progresses to a more distributed treatment schedule.
Interventions
- BEHAVIORAL Biofeedback
- BEHAVIORAL Speech Motor Chaining without Biofeedback
- BEHAVIORAL Distributed Practice
- BEHAVIORAL Massed --> Distributed Practice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2022-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03238677
The ClinicalTrials.gov registry entry for NCT03238677 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syracuse University, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Biofeedback is the first listed.
NCT03238677 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03238677 about?
NCT03238677 is a clinical study titled "Treating Childhood Apraxia of Speech". The study will test two modifications to speech therapy for 40 school-age children with childhood apraxia of speech to determine how to improve treatment outcomes. The study will compare treatment that includes real-time visual feedback of the tongue during speech using ultrasound vs traditional the...
What is the current status of trial NCT03238677?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2017-08-01. Estimated completion is 2022-06-07.
What interventions are being tested in trial NCT03238677?
The interventions under investigation include: Biofeedback (BEHAVIORAL), Speech Motor Chaining without Biofeedback (BEHAVIORAL), Distributed Practice (BEHAVIORAL), Massed --> Distributed Practice (BEHAVIORAL).
Who is sponsoring clinical trial NCT03238677?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.